Sidley and DLA Piper have advised Softcare. Herbert Smith Freehills Kramer has advised the underwriters. Softcare Limited (Softcare) has completed its initial public offering and listing...
Softcare Raises HK$2.38 Billion in Hong Kong IPO
SF Holding Completes HK$5.9 Billion Fundraising Through Share Placement and Convertible Bond Issuance
Linklaters has advised the joint lead managers. Herbert Smith Freehills Kramer has advised S.F. Holding Co., Ltd. S.F. Holding Co., Ltd., the largest comprehensive logistics service...
S.F. Holding’s $750 Million IPO On HKSE
Herbert Smith Freehills advised SF Holding on the deal, while Clifford Chance advised the underwriters. S.F. Holding Co., Ltd. completed its global offering and listing on...
TS Lines’ IPO on Hong Kong Stock Exchange
Herbert Smith Freehills advised joint sponsors on T.S. Lines’ Hong Kong IPO. T.S. Lines Limited (02510.HK) completed its listing on the Main Board of the Hong...
MMG’s HK$9bn Rights Issue
Herbert Smith Freehills advised MMG on rights issue. MMG Limited (01208.HK) successfully completed a HK$9 billion rights issue, marking one of the largest equity fundraising efforts...
Cutia Therapeutics’ IPO on Hong Kong Market
Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on the listing. Cutia Therapeutics, a company with operations in Beijing, Hong Kong, Shanghai,...
MedSci Healthcare Holdings Limited’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills has advised China International Capital Corporation Hong Kong Securities Limited, and Macquarie Capital Limited. MedSci Healthcare operates one of the largest online professional...
Lygend Resources & Technology Co., Ltd.’s Mainboard Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills advised CICC and CMB International as joint sponsors and underwriters. T&C Law Firm advised Lygend on the deal. Lygend is Hong Kong’s 6th...
Jenscare Scientific’s Hong Kong IPO
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
Biocytogen Pharmaceuticals’ Listing on the Main Board of the Hong Kong Stock Exchange
Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the company’s official listing...
Sanxun Holdings’ US$100.9 Million IPO
Sidley Austin, working alongside Conyers, advised Sanxun Holdings Group Limited on the deal. Sanxun Holdings Group Limited (HKEX:6611) (Sanxun Holdings) announced its initial public offering (IPO)...
Dexin Services Group Limited’s US$89.8 Million IPO
Sidley Austin and Conyers advised Dexin Services Group Limited on the deal while Paul Hastings advised CCB International Capital Limited. Dexin Services Group Limited (HKEX:2215) (Dexin...